It was shown, for example, that sEV levels of both phosphorylated tau and amyloid beta (Aβ) proteins detected in the blood of AD patients were significantly higher than in controls, from 1 to 10 years before disease diagnosis (Fiandaca et al., 2015). This evidence concerns the gene MAPT and Alzheimer disease.